| Authors: |
Burbidge O; Department of Pharmacology, University of Cambridge, Tennis Court Road, CB2 1PD Cambridge, UK., Pastok MW; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Framlington Place, NE2 4HH Newcastle upon Tyne, UK., Papini D; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Framlington Place, NE2 4HH Newcastle upon Tyne, UK., Hodder SL; Department of Pharmacology, University of Cambridge, Tennis Court Road, CB2 1PD Cambridge, UK., Zenkevičiūtė G; Department of Pharmacology, University of Cambridge, Tennis Court Road, CB2 1PD Cambridge, UK., Tan KZJ; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Framlington Place, NE2 4HH Newcastle upon Tyne, UK., Turberville S; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Framlington Place, NE2 4HH Newcastle upon Tyne, UK., Noble MEM; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Framlington Place, NE2 4HH Newcastle upon Tyne, UK., Endicott JA; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Framlington Place, NE2 4HH Newcastle upon Tyne, UK. Electronic address: jane.endicott@ncl.ac.uk., Itzhaki L; Department of Pharmacology, University of Cambridge, Tennis Court Road, CB2 1PD Cambridge, UK. Electronic address: lsi10@cam.ac.uk. |
